FCM
Farallon Capital Management’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-939,212
| Closed | -$152M | – | 193 |
|
|
2022
Q4 | $152M | Buy |
939,212
+214,100
| +30% | +$34.6M | 0.9% | 38 |
|
|
2022
Q3 | $97.3M | Buy |
725,112
+219,597
| +43% | +$29.5M | 0.53% | 50 |
|
|
2022
Q2 | $77.4M | Sell |
505,515
-639,152
| -56% | -$97.9M | 0.42% | 60 |
|
|
2022
Q1 | $186M | Sell |
1,144,667
-463,784
| -29% | -$75.2M | 0.9% | 33 |
|
|
2021
Q4 | $218M | Buy |
1,608,451
+1,126,603
| +234% | +$153M | 1.09% | 27 |
|
|
2021
Q3 | $52M | Buy |
+481,848
| New | +$52M | 0.24% | 71 |
|
|
2021
Q1 | – | Sell |
-1,150,000
| Closed | -$123M | – | 237 |
|
|
2020
Q4 | $123M | Sell |
1,150,000
-3,100,000
| -73% | -$332M | 0.74% | 42 |
|
|
2020
Q3 | $372M | Buy |
4,250,000
+100,000
| +2% | +$8.76M | 2.57% | 10 |
|
|
2020
Q2 | $407M | Buy |
4,150,000
+150,000
| +4% | +$14.7M | 3.26% | 5 |
|
|
2020
Q1 | $305M | Buy |
4,000,000
+1,500,000
| +60% | +$114M | 2.62% | 9 |
|
|
2019
Q4 | $221M | Buy |
2,500,000
+1,500,000
| +150% | +$133M | 1.49% | 21 |
|
|
2019
Q3 | $75.7M | Buy |
+1,000,000
| New | +$75.7M | 0.57% | 41 |
|
|
2018
Q1 | – | Sell |
-700,000
| Closed | -$67.7M | – | 85 |
|
|
2017
Q4 | $67.7M | Buy |
700,000
+115,000
| +20% | +$11.1M | 0.55% | 35 |
|
|
2017
Q3 | $52M | Sell |
585,000
-250,000
| -30% | -$22.2M | 0.46% | 44 |
|
|
2017
Q2 | $60.5M | Buy |
+835,000
| New | +$60.5M | 0.63% | 32 |
|
|
2017
Q1 | – | Sell |
-160,000
| Closed | -$10M | – | 70 |
|
|
2016
Q4 | $10M | Buy |
+160,000
| New | +$10M | 0.12% | 52 |
|
|
2015
Q4 | – | Sell |
-722,000
| Closed | -$39.3M | – | 63 |
|
|
2015
Q3 | $39.3M | Buy |
722,000
+437,000
| +153% | +$23.8M | 0.52% | 41 |
|
|
2015
Q2 | $19.1M | Buy |
+285,000
| New | +$19.1M | 0.26% | 53 |
|